Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Oliver Wyman

The Inflation Reduction Act could lead to broader changes in drug development and pricing.

Partner, Health and Life Sciences, Oliver Wyman

Healthcare affordability is an issue for many employees, especially with inflation stressing household budgets. Employers are trying to keep more money in employees’ paychecks and remove cost barriers when care is needed.

Director of Research, Health, Mercer
Partner, Chief Actuary, Mercer
Senior Partner, National Leader for U.S. Health Policy

Despite a slowdown in deal making, pharmaceuticals and healthtech continue to get attention from investors.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, HLS Private Capital, Oliver Wyman
Consultant, HLS Private Capital, Oliver Wyman

Commercial group lines of business have experienced flat growth in recent years. Health plans need to strengthen their fundamentals and tightly coordinate operations to achieve meaningful top line growth.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

The best way to start fighting burnout is to build trust and open communication so you can truly understand the factors that are contributing to it.

CEO, CHG Healthcare

Insights in your inbox

Subscribe

Interoperability standards and consumer protection hold the key to the growth of these virtual worlds.

Senior Analyst, Oliver Wyman Forum
Senior Fellow, Oliver Wyman Forum
Partner, Oliver Wyman Forum

What the $3.9 billion deal could mean for the industry

Insights on potential near-term and long-term impact for consumers, employers, and incumbents.

Partner, Health Services, Oliver Wyman

The digital model transition has advanced since the pandemic, directing millions of people online for everything from payments to performing their jobs.

Partner, Digital, Oliver Wyman

The record pace of investment in healthcare spurred a lot of innovation, but now it’s time to tackle more complex problems.

Global Leader, Health and Life Sciences, Oliver Wyman
Managing Director, General Catalyst

The current economic climate opens the door for investors and innovators to rethink partnerships and ways to access capital.

Partner, Health and Life Sciences, Oliver Wyman
Senior Editor, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe